Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity.

ABSTRACT:

SUBMITTER: Li P 

PROVIDER: S-EPMC12579341 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature